MY HUYNH: Open Payments
NPI 1639675564 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 38 payments from 15 companies in 2025. Trend: 2023 $1,117 · 2024 $1,443 · 2025 $1,188
Food & beverage: $1,188
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $267 |
| Novo Nordisk Inc | 6 | $198 |
| Madrigal Pharmaceuticals | 2 | $183 |
| Viatris Specialty LLC | 2 | $152 |
| Amgen Inc. | 4 | $107 |
| Lilly USA, LLC | 2 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| Radius Health, Inc. | 1 | $29 |
| Medtronic, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: LINZESS, REZDIFFRA, Wegovy, YUPELRI, ZENPEP, CREON, EVENITY, Tymlos.
Industry payments across TX — which companies pay providers there.
